Cecelia Patricia Johnson-Sasso

Cecelia Johnson-Sasso practices at Colorado Physicians Partners in Denver, Colorado.

Cecelia Johnson-Sasso's NPI, 1760986582, was assigned on March 19, 2018. Cecelia Johnson-Sasso holds Illinois license 125.072558.

Cecelia Johnson-Sasso's primary practice is Colorado Physicians Partners, at 999 17th St, Denver, CO 80202 in Denver County. The practice phone is (720) 728-5170.

Cecelia Johnson-Sasso's primary practice is Colorado Physicians Partners in Denver, Colorado. Cecelia Johnson-Sasso is also affiliated with AdventHealth Littleton. The medical group on file is US Acute Care Solutions. Dmand AI also links Cecelia Johnson-Sasso to 1 more hospital, 5 medical groups, 4 group practices and clinics and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cecelia Johnson-Sasso practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Cecelia Johnson-Sasso's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Cecelia Johnson-Sasso is licensed in Illinois.

CMS data shows 144 Medicare services from Cecelia Johnson-Sasso across 3 procedure codes in 2024, for 147 Medicare patients. Medicare paid $18,441 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 147 Medicare patients who saw Cecelia Johnson-Sasso in 2024. The largest group is 75 to 84, with 46 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Cecelia Johnson-Sasso's median patient age at 70, with 71% women.

In 2024, Cecelia Johnson-Sasso wrote 126 Medicare Part D claims for 98 patients. 94% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $269 in total drug cost. In 2019, CMS named 72 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Cecelia Johnson-Sasso for performance year 2024, reported as part of a group. Cecelia Johnson-Sasso accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Cecelia Johnson-Sasso as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Cecelia Johnson-Sasso, published from 2018 to 2022. 2021 was the busiest year, with 2. The most frequent topics are Myocardial Infarction. Cecelia Johnson-Sasso's most frequent co-authors are Aaron Sal Parzuchowski, MD, MPH, MS and Anju T. Peters, MD.

CMS Open Payments shows 19 general payments to Cecelia Johnson-Sasso from 13 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $76.